top of page
Why it’s Different
Unlike static or single-motion phantoms, M³Phantom captures multi-organ, multi-motion interactions that generate real imaging artifacts. It supports functional and anatomical imaging together — not anatomy alone. Its modular architecture, motion control software, and proprietary materials make it fundamentally difficult to replicate.
Complex, interrelated system is very difficult to replicate
Integration
of materials
Real-time motion control software
Calibration & interconnect electronics with control
Proprietary phantom materials
What it Enables
M³Phantom enables realistic protocol optimization, motion-correction validation, AI training, dosimetry studies and calibrations. Clinicians can distinguish true disease from artifacts, while researchers test algorithms against known ground truth. Educators gain a powerful tool for training under clinically realistic conditions.
Motion cardiac artifact or real disease
Who it’s For
Designed for hospitals, imaging departments, oncology centers, research labs, and universities. Equally valuable to medical imaging manufacturers and phantom companies seeking differentiation and validation. Used by physicians, medical physicists, technologists, researchers, and AI developers.
Who it’s For
Market
& Expansion
The global imaging phantom market is growing steadily, driven by quantitative imaging, AI, and regulatory pressure. M³Phantom addresses an unmet segment: realistic thoracic motion across multiple modalities. Its modular design allows expansion across organs, diseases, body types, and future imaging workflows.
Total Market Size*:
191 million USD (2025)
260 million USD (2030)
*Grand View Research (2025). Medical Imaging Phantoms Market Size 2030
Rapid market growth for gold standard
or nuclear medicine imaging
M3Phantom improve diagnosis & training
Why it’s Affordable
M³Phantom is offered as a scalable platform rather than a one-size-fits-all system. Institutions can start with a core configuration and add modules over time as needs and budgets evolve. This lowers entry barriers while preserving long-term value.
Why it’s Ready
M³Phantom has reached TRL-7, with more than 1,500 hours of imaging validation across six international hospitals. It has been tested using clinical protocols and commercial reconstruction algorithms.
Supporters
Your loyalty means the world to us! Thank you for being a part of
our journey.
bottom of page